Aurobindo Pharma got final approval from the US Food & Drug Administration (US FDA) to manufacture and market generic drug, Piperacillin and Tazobactam injection of varying strength packed in single use vials, the company said in a press release Tuesday.
first published: May 24, 2011 12:33 pm
A collection of the most-viewed Moneycontrol videos.

Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live

Live: RBI Policy Expectations| Rupee Slide, Strong GDP & Soft Inflation – Will MPC Cut Or Pause?

Nifty Holds Key Support; Volatile Trade Likely on Sensex Expiry | Opening Bell Live

Rupee Slide Weighs Heavy As Nifty Tests 25,900| Midcaps See Sharp Cuts| Closing Bell Live
You are already a Moneycontrol Pro user.

